NASDAQ:ZYBT

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results

JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines inChina, toda...

2025-07-03 20:30 4381

Week's Top Stories

Most Reposted

Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals

[Picked up by 313 media titles]

2025-12-10 10:00
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals

HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City

[Picked up by 306 media titles]

2025-12-09 13:31
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City

ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering

[Picked up by 293 media titles]

2025-12-11 09:07
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering

BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025

[Picked up by 288 media titles]

2025-12-08 11:00
BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025

Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records

[Picked up by 286 media titles]

2025-12-10 16:00
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records

Most Read

VisIC Technologies Announces $26M Round B Investment Led by Global Semiconductor Leader; Hyundai Motor Company and Kia (Together as "HKMC") Joins as Strategic Investor

2025-12-10 15:00 3266

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

2025-12-10 21:00 2898

Noah Holdings Hosts Global Black Diamond Summit, Highlights Vision for AI-Driven Global Wealth Management Future

2025-12-11 11:21 2558

51Talk Online Education Group Announces Third Quarter 2025 Results

2025-12-08 19:30 2443

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Reports Unaudited Financial Results for the Six Months Ended June 30, 2025

2025-12-08 22:15 2427